GXO Logistics, Inc. Q3 FY2025 earnings call

Key Points

• Patrick Kelleher, CEO, welcomes the call, notes record revenue and adjusted EBITDA growth, and highlights the smooth transition from his predecessor. He discusses opportunities in North America, the new President of the Americas and Asia Pacific region, Michael Jacobs, and focuses on high-growth verticals like life sciences, aerospace, defense, and data centers.
• Baris Oran, CFO, confirms record revenue, adjusted EBITDA growth, margin expansion, and reaffirms full-year guidance. He mentions the progress of the Wincanton integration and disciplined capital allocation.
• Kristine Kubacki, Chief Strategy Officer, details new business wins, progress in verticals such as life sciences (with the NHS contract launch), aerospace/defense, and data centers, and highlights a robust sales pipeline with diversified opportunities.

In the third quarter of 2025, GXO achieved record quarterly revenue of $3.4 billion. Adjusted EBITDA grew 13% year-over-year to $251 million. New business wins totaled $280 million, up 24% year-over-year. Organic revenue growth was seen across every region. While specific segment revenue contributions aren't detailed, key verticals like retail, CPG, aerospace, defense, industrial, life sciences, and data centers are highlighted as areas of focus and growth.

Guidance

• Reaffirmed 2025 guidance includes organic revenue growth of 3.5% to 6.5%, adjusted EBITDA of $865 million to $885 million, adjusted diluted earnings per share of $2.43 to $2.63, and adjusted EBITDA to free cash flow conversion of 25% to 35%.
• For Q4, expects more contribution from new business, including the NHS contract ramp-up, but anticipates softer volume trends while remaining within full-year guidance.

Risks

• Factors such as fluctuations in foreign exchange rates, changes in global economic conditions, consumer demand and spending, labor market constraints, global supply chain issues, and inflationary pressures. The unpredictability of demand can materially affect actual results compared to guidance.

Q: Stephanie Moore asked about North America opportunities and 2025 guidance.

A: Patrick Kelleher discussed the potential in North America with new leadership and focus on high-growth verticals, and Baris Oran commented on Q4 organic growth expectations.

Q: Scott Schneeberger inquired about the business mix in a few years.

A: Patrick Kelleher mentioned focusing on core business but expanding into high-growth verticals, with details to be shared at the 2026 Investor Day.

Q: Chris Wetherbee asked about margin expansion and Q4 organic growth.

A: Patrick Kelleher talked about structural margin opportunities and Baris Oran discussed Q4 expectations within full-year guidance.

Q: Brian Ossenbeck asked about technology deployment.

A: Patrick Kelleher spoke about GXO's technology capabilities, GXO IQ platform, and AI module deployments.

Q: Ravi Shanker asked about customer thoughts on the environment and GXO's role.

A: Patrick Kelleher and Kristine Kubacki discussed customer needs and GXO's value in solving supply chain complexities.

Q: Jason Seidl asked about margin differences in new verticals and 4Q outlook.

A: Patrick Kelleher and Baris Oran provided insights on margin opportunities and Q4 volume trends.

Q: Ariel Rosa asked about GXO's attractions and COO role.

A: Patrick Kelleher discussed GXO's culture, people, and the COO's focus on operational best practices.

Q: Richa Talwar asked about Wincanton synergies.

A: Baris Oran mentioned cost synergies progress and deferred revenue synergy details to be shared at the 2026 Investor Day.

Q: Bruce Chan asked about Wincanton pipeline and margins.

A: Kristine Kubacki and Baris Oran discussed Wincanton pipeline inclusion and margin differentials.

Q: Bascome Majors asked about growth drivers and M&A.

A: Patrick Kelleher emphasized organic growth as primary, with M&A considered but not short-term.

Q: Patrick Creuset asked about U.S. growth and margin potential.

A: Patrick Kelleher discussed U.S. market opportunity and margin aspirations to be detailed at the 2026 Investor Day